Skip to main content
. 2018 Jun 12;6(8):1161–1168. doi: 10.1177/2050640618784340

Table 1.

Clinical, serological and histological features of adult coeliac patients (CD) classified on the basis of bone mineral density (BMD) results.

Pts with normal BMD n = 85 (39.7%) Pts with osteopenia n = 91 (42.5%) Pts with osteoporosis n = 38 (17.8%) p valuea p valueb p valuec
Clinical features and lifestyle items
 Female gender % 82.3 69.2 52.6 0.05 <0.001 0.10
 Age, median (range) 38 (19–64) 36 (18–72) 48.5 (19–72) 0.79 <0.001 <0.001
 BMI, kg/m2, median (range) 22.8 (16.8–38.2) 21.05 (16.7–32.8) 19.8 (16–28.5) 0.001 <0.001 0.16
 Underweight (BMI ≤ 18.5 kg/m2) % 6.2 20.5 30.5 0.01 <0.001 0.25
 GI symptoms leading to CD diagnosis % 38.8 57.1 65.8 0.02 0.03 0.84
 Anaemia % 52.4 52.9 45.9 1 0.56 0.56
 Presence of symptoms ≥5 years  before CD diagnosis % 38 32.4 35.5 0.98 1 0.80
 Familiarity for coeliac disease % 17.8 17.9 11.1 1 0.42 0.43
 Post-menopausal female % 4.8 3.3 23.7 0.71 <0.001 <0.001
 Autoimmune comorbidities % 31.3 31.8 30.5 1 1 1
 Previous bone fractures % 14.3 20.5 41.9 0.38 0.004 0.03
 Drugs % 2.4 4.6 2.6 0.68 1 1
 Smoking % 28 29 34.2 1 0.52 0.67
 Alcohol (≥3 units daily) % 1.2 4.6 10.5 0.37 0.03 0.25
Serological parameters
 Positivity to anti-EMA and/or  TTG IgA autoantibodies % 84.7 89.1 86.8 0.50 1 0.72
 Increased PTH values % 19.7 31.1 54.3 0.13 <0.001 0.03
 Ferritin, ng/ml, median (range) 11 (1–186) 9 (2–188) 9.5 (2-89) 0.59 0.47 0.86
 Cholesterol, mg/ml, median (range) 171 (100–257) 168 (98–280) 168 (93-246) 0.41 0.36 0.73
 Triglycerides, mg/ml, median (range) 64.5 (28–160) 70 (30–216) 76 (36-171) 0.47 0.06 0.18
 Albumin, g/dl, median (range) 4.1 (3.1–5.0) 4.2 (3.0–5.6) 4.05 (1.6-4.9) 0.51 0.25 0.42
Histology
 Marsh 3C % 42.3 54.9 55.3 0.23 0.24 0.70

Pts: patients; BMI: body mass index; EMA: Anti-endomysium immunoglobulin A antibodies; tTG: anti-transglutaminase immunoglobulin A antibodies; GI: gastrointestinal; PTH: parathormone.

a

Normal BMD vs osteopenia. bNormal BMD vs osteoporosis. cOsteopenia vs osteoporosis.